CA2199756A1 - Mobilisation de cellules utilisant un traitement in vivo avec l'hyaluronan (ha) - Google Patents
Mobilisation de cellules utilisant un traitement in vivo avec l'hyaluronan (ha)Info
- Publication number
- CA2199756A1 CA2199756A1 CA002199756A CA2199756A CA2199756A1 CA 2199756 A1 CA2199756 A1 CA 2199756A1 CA 002199756 A CA002199756 A CA 002199756A CA 2199756 A CA2199756 A CA 2199756A CA 2199756 A1 CA2199756 A1 CA 2199756A1
- Authority
- CA
- Canada
- Prior art keywords
- hyaluronic acid
- cells
- daltons
- molecular weight
- acceptable salts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002199756A CA2199756A1 (fr) | 1996-03-14 | 1997-03-12 | Mobilisation de cellules utilisant un traitement in vivo avec l'hyaluronan (ha) |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60/013,401 | 1996-03-14 | ||
| CA002199756A CA2199756A1 (fr) | 1996-03-14 | 1997-03-12 | Mobilisation de cellules utilisant un traitement in vivo avec l'hyaluronan (ha) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2199756A1 true CA2199756A1 (fr) | 1998-09-12 |
Family
ID=4160153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002199756A Abandoned CA2199756A1 (fr) | 1996-03-14 | 1997-03-12 | Mobilisation de cellules utilisant un traitement in vivo avec l'hyaluronan (ha) |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2199756A1 (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006072243A1 (fr) * | 2005-01-03 | 2006-07-13 | Novozymes Biopolymer A/S | Fraction acide hyaluronique ayant des proprietes hydratantes et antirides |
-
1997
- 1997-03-12 CA CA002199756A patent/CA2199756A1/fr not_active Abandoned
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006072243A1 (fr) * | 2005-01-03 | 2006-07-13 | Novozymes Biopolymer A/S | Fraction acide hyaluronique ayant des proprietes hydratantes et antirides |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20090029941A1 (en) | Methods for cell mobilization using in vivo treatment with hyaluronan (ha) | |
| AU2004242091B2 (en) | Administration of hyaluronic acid to enhance the function of transplanted stem cells | |
| Sun et al. | CD39/ENTPD1 expression by CD4+ Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice | |
| Smyth et al. | Differential tumor surveillance by natural killer (NK) and NKT cells | |
| Laurent et al. | Hyaluronan 1 | |
| Bar-Yehuda et al. | Resistance of muscle to tumor metastases: a role for a3 adenosine receptor agonists | |
| Currier et al. | Effect over time of in-vivo administration of the polysaccharide arabinogalactan on immune and hemopoietic cell lineages in murine spleen and bone marrow | |
| JP5662309B2 (ja) | 腫瘍性疾患を治療するための組成物および方法 | |
| Irintchev et al. | Cellular and molecular reactions in mouse muscles after myoblast implantation | |
| CN114306615B (zh) | 脆弱拟杆菌荚膜多糖a与免疫检查点抑制剂的新应用 | |
| EP0914133B1 (fr) | Utilisation de l'hyaluronane (ha) pour la mobilisation cellulaire | |
| US20050113335A1 (en) | Methods for cell mobilization using in vivo treatment with hyaluronan (HA) | |
| JP7591564B2 (ja) | 変形性関節症を治療するための治療用アポトーシス細胞 | |
| JP3150967B2 (ja) | 二本鎖ｒｎａによる損傷に続くショックからの保護 | |
| Halaas et al. | Mannuronan enhances survival of lethally irradiated mice and stimulates murine haematopoiesis in vitro | |
| CA2199756A1 (fr) | Mobilisation de cellules utilisant un traitement in vivo avec l'hyaluronan (ha) | |
| Kelsey et al. | Functional significance of induction of differentiation in human myeloid leukaemic blasts by 1, 25-dihydroxyvitamin D3 and GM-CSF | |
| Balazs et al. | Interaction of amino sugars and amino sugar-containing macromolecules with viruses, cells, and tissues | |
| CA2520400A1 (fr) | Traitement d'infections par aspergillus a l'aide de thymosine alpha 1 | |
| WO2021155479A1 (fr) | Procédés d'amélioration de lymphocytes t par vénétoclax | |
| Tuttle et al. | Adoptive transfer of bryostatin 1-activated T cells provides long-term protection from tumour metastases | |
| Vincent-Naulleau et al. | Stimulatory effects of polar glycopeptidolipids of Mycobacterium chelonae on murine haematopoietic stem cells and megakaryocyte progenitors | |
| FR2691066A1 (fr) | Utilisation de glycosaminoglycanes exogènes, de leurs analogues ainsi que de leurs fragments, fractions et dérivés, pour la préparation de médicaments destinés au traitement de thrombopénies. | |
| CA2173272C (fr) | Stimulation de cellules souches et d'autres cellules | |
| Vanclée et al. | Murine dendritic cells that are resistant to maturation are unable to induce tolerance to allogeneic stem cells |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Dead |